Shell Companies
Compare Stocks
4 / 10Stock Comparison
ALCY vs BN vs KKR vs APO
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management - Global
ALCY vs BN vs KKR vs APO — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Shell Companies | Asset Management | Asset Management | Asset Management - Global |
| Market Cap | $119M | $104.40B | $89.45B | $73.67B |
| Revenue (TTM) | $0.00 | $77.66B | $19.26B | $30.30B |
| Net Income (TTM) | $3M | $1.31B | $2.37B | $4.48B |
| Gross Margin | — | 40.0% | 41.8% | 88.5% |
| Operating Margin | — | 39.9% | 2.4% | 34.4% |
| Forward P/E | 27.8x | 16.7x | 16.4x | 14.4x |
| Total Debt | $530K | $263.42B | $54.77B | $13.36B |
| Cash & Equiv. | $181K | $16.24B | $6M | $19.24B |
ALCY vs BN vs KKR vs APO — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 23 | May 26 | Return |
|---|---|---|---|
| Alchemy Investments… (ALCY) | 100 | 117.3 | +17.3% |
| Brookfield Corporat… (BN) | 100 | 199.9 | +99.9% |
| KKR & Co. Inc. (KKR) | 100 | 169.0 | +69.0% |
| Apollo Global Manag… (APO) | 100 | 156.4 | +56.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALCY vs BN vs KKR vs APO
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALCY is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.02, Low D/E 10.4%, current ratio 0.13x
- Beta 0.02 vs KKR's 1.70, lower leverage
BN carries the broadest edge in this set and is the clearest fit for quality and momentum.
- Efficiency ratio 0.0% vs APO's 0.5% (lower = leaner)
- +25.5% vs KKR's -13.0%
- Efficiency ratio 0.0% vs APO's 0.5%
KKR is the clearest fit if your priority is dividends.
- 0.8% yield, 6-year raise streak, vs APO's 1.7%, (2 stocks pay no dividend)
APO is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 3 yrs, beta 1.43, yield 1.7%
- Rev growth 16.0%, EPS growth -1.0%
- 7.6% 10Y total return vs KKR's 7.2%
- Beta 1.43, yield 1.7%, current ratio 0.78x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.0% NII/revenue growth vs KKR's -11.0% | |
| Value | Lower P/E (14.4x vs 27.8x) | |
| Quality / Margins | Efficiency ratio 0.0% vs APO's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.02 vs KKR's 1.70, lower leverage | |
| Dividends | 0.8% yield, 6-year raise streak, vs APO's 1.7%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +25.5% vs KKR's -13.0% | |
| Efficiency (ROA) | Efficiency ratio 0.0% vs APO's 0.5% |
ALCY vs BN vs KKR vs APO — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ALCY vs BN vs KKR vs APO — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
APO leads in 1 of 6 categories
BN leads 1 • ALCY leads 0 • KKR leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — BN and APO each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
BN and ALCY operate at a comparable scale, with $77.7B and $0 in trailing revenue. APO is the more profitable business, keeping 14.8% of every revenue dollar as net income compared to BN's 1.7%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $77.7B | $19.3B | $30.3B |
| EBITDAEarnings before interest/tax | -$1M | $32.1B | $9.0B | $11.5B |
| Net IncomeAfter-tax profit | $3M | $1.3B | $2.4B | $4.5B |
| Free Cash FlowCash after capex | -$907,212 | -$2.8B | $7.5B | $5.4B |
| Gross MarginGross profit ÷ Revenue | — | +40.0% | +41.8% | +88.5% |
| Operating MarginEBIT ÷ Revenue | — | +39.9% | +2.4% | +34.4% |
| Net MarginNet income ÷ Revenue | — | +1.7% | +12.3% | +14.8% |
| FCF MarginFCF ÷ Revenue | — | — | +49.4% | +24.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -170.4% | +73.1% | -1.7% | +16.3% |
Valuation Metrics
APO leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 17.6x trailing earnings, APO trades at a 100% valuation discount to BN's 9999.0x P/E. On an enterprise value basis, APO's 5.9x EV/EBITDA is more attractive than KKR's 20.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $119M | $104.4B | $89.4B | $73.7B |
| Enterprise ValueMkt cap + debt − cash | $119M | $351.6B | $144.2B | $67.8B |
| Trailing P/EPrice ÷ TTM EPS | 27.81x | 9999.00x | 42.88x | 17.60x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 16.69x | 16.42x | 14.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 0.23x |
| EV / EBITDAEnterprise value multiple | — | 8.53x | 20.24x | 5.92x |
| Price / SalesMarket cap ÷ Revenue | — | 1.34x | 4.64x | 2.43x |
| Price / BookPrice ÷ Book value/share | 23.38x | 0.66x | 1.17x | 1.83x |
| Price / FCFMarket cap ÷ FCF | — | — | 9.39x | 9.89x |
Profitability & Efficiency
Evenly matched — ALCY and APO each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
ALCY delivers a 52.9% return on equity — every $100 of shareholder capital generates $53 in annual profit, vs $1 for BN. ALCY carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to BN's 1.59x. On the Piotroski fundamental quality scale (0–9), KKR scores 6/9 vs APO's 3/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +52.9% | +0.8% | +3.2% | +12.1% |
| ROA (TTM)Return on assets | +20.3% | +0.3% | +0.6% | +1.0% |
| ROICReturn on invested capital | -1.5% | +5.6% | +0.3% | +16.0% |
| ROCEReturn on capital employed | -1.8% | +7.2% | +0.1% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 6 | 3 |
| Debt / EquityFinancial leverage | 0.10x | 1.59x | 0.67x | 0.31x |
| Net DebtTotal debt minus cash | $348,826 | $247.2B | $54.8B | -$5.9B |
| Cash & Equiv.Liquid assets | $181,174 | $16.2B | $6M | $19.2B |
| Total DebtShort + long-term debt | $530,000 | $263.4B | $54.8B | $13.4B |
| Interest CoverageEBIT ÷ Interest expense | -10.99x | 1.64x | 3.29x | 28.98x |
Total Returns (Dividends Reinvested)
BN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in APO five years ago would be worth $23,514 today (with dividends reinvested), compared to $11,680 for ALCY. Over the past 12 months, BN leads with a +25.5% total return vs KKR's -13.0%. The 3-year compound annual growth rate (CAGR) favors BN at 30.5% vs ALCY's 5.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -17.2% | -0.1% | -22.0% | -12.5% |
| 1-Year ReturnPast 12 months | +2.9% | +25.5% | -13.0% | +0.4% |
| 3-Year ReturnCumulative with dividends | +16.8% | +122.1% | +107.7% | +115.8% |
| 5-Year ReturnCumulative with dividends | +16.8% | +89.3% | +76.5% | +135.1% |
| 10-Year ReturnCumulative with dividends | +16.8% | +308.9% | +715.5% | +759.2% |
| CAGR (3Y)Annualised 3-year return | +5.3% | +30.5% | +27.6% | +29.2% |
Risk & Volatility
Evenly matched — ALCY and BN each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALCY is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than KKR's 1.70 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BN currently trades 93.8% from its 52-week high vs KKR's 65.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.02x | 1.57x | 1.70x | 1.43x |
| 52-Week HighHighest price in past year | $15.90 | $49.57 | $153.87 | $157.28 |
| 52-Week LowLowest price in past year | $10.25 | $36.47 | $82.67 | $99.56 |
| % of 52W HighCurrent price vs 52-week peak | +75.2% | +93.8% | +65.2% | +81.3% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 62.5 | 52.4 | 64.9 |
| Avg Volume (50D)Average daily shares traded | 2K | 5.9M | 6.5M | 5.2M |
Analyst Outlook
Evenly matched — KKR and APO each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BN as "Buy", KKR as "Buy", APO as "Buy". Consensus price targets imply 42.5% upside for KKR (target: $143) vs 17.0% for BN (target: $54). For income investors, APO offers the higher dividend yield at 1.67% vs KKR's 0.80%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $54.40 | $143.00 | $157.25 |
| # AnalystsCovering analysts | — | 9 | 26 | 28 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.8% | +1.7% |
| Dividend StreakConsecutive years of raises | — | 1 | 6 | 3 |
| Dividend / ShareAnnual DPS | — | — | $0.80 | $2.14 |
| Buyback YieldShare repurchases ÷ mkt cap | +96.0% | 0.0% | +0.1% | +1.0% |
APO leads in 1 of 6 categories (Valuation Metrics). BN leads in 1 (Total Returns). 4 tied.
ALCY vs BN vs KKR vs APO: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALCY or BN or KKR or APO a better buy right now?
For growth investors, Apollo Global Management, Inc.
(APO) is the stronger pick with 16. 0% revenue growth year-over-year, versus -11. 0% for KKR & Co. Inc. (KKR). Apollo Global Management, Inc. (APO) offers the better valuation at 17. 6x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Brookfield Corporation (BN) a "Buy" — based on 9 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALCY or BN or KKR or APO?
On trailing P/E, Apollo Global Management, Inc.
(APO) is the cheapest at 17. 6x versus Brookfield Corporation at 9999. 0x. On forward P/E, Apollo Global Management, Inc. is actually cheaper at 14. 4x.
03Which is the better long-term investment — ALCY or BN or KKR or APO?
Over the past 5 years, Apollo Global Management, Inc.
(APO) delivered a total return of +135. 1%, compared to +16. 8% for Alchemy Investments Acquisition Corp 1 (ALCY). Over 10 years, the gap is even starker: APO returned +759. 2% versus ALCY's +16. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALCY or BN or KKR or APO?
By beta (market sensitivity over 5 years), Alchemy Investments Acquisition Corp 1 (ALCY) is the lower-risk stock at 0.
02β versus KKR & Co. Inc. 's 1. 70β — meaning KKR is approximately 8592% more volatile than ALCY relative to the S&P 500. On balance sheet safety, Alchemy Investments Acquisition Corp 1 (ALCY) carries a lower debt/equity ratio of 10% versus 159% for Brookfield Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — ALCY or BN or KKR or APO?
By revenue growth (latest reported year), Apollo Global Management, Inc.
(APO) is pulling ahead at 16. 0% versus -11. 0% for KKR & Co. Inc. (KKR). On earnings-per-share growth, the picture is similar: Alchemy Investments Acquisition Corp 1 grew EPS 34. 4% year-over-year, compared to -99. 8% for Brookfield Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALCY or BN or KKR or APO?
Apollo Global Management, Inc.
(APO) is the more profitable company, earning 14. 8% net margin versus 0. 0% for Alchemy Investments Acquisition Corp 1 — meaning it keeps 14. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BN leads at 39. 9% versus 0. 0% for ALCY. At the gross margin level — before operating expenses — APO leads at 88. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALCY or BN or KKR or APO more undervalued right now?
On forward earnings alone, Apollo Global Management, Inc.
(APO) trades at 14. 4x forward P/E versus 16. 7x for Brookfield Corporation — 2. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KKR: 42. 5% to $143. 00.
08Which pays a better dividend — ALCY or BN or KKR or APO?
In this comparison, APO (1.
7% yield), KKR (0. 8% yield) pay a dividend. ALCY, BN do not pay a meaningful dividend and should not be held primarily for income.
09Is ALCY or BN or KKR or APO better for a retirement portfolio?
For long-horizon retirement investors, Alchemy Investments Acquisition Corp 1 (ALCY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
02)). Brookfield Corporation (BN) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALCY: +16. 8%, BN: +308. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALCY and BN and KKR and APO?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ALCY is a small-cap quality compounder stock; BN is a mid-cap quality compounder stock; KKR is a mid-cap quality compounder stock; APO is a mid-cap high-growth stock. KKR, APO pay a dividend while ALCY, BN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.